MAZE
Maze Therapeutics, Inc.Company with tickers: MAZE
Market Cap
$1.57B
Shares Outstanding
55,345,261
CIK
1842295
CUSIP
578784100
Investor Relations
Investor relations
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-01 | Coloma Jason V | Officer | 34,501 | 2026-06-01 | UBS Financial Services Inc. |
| 2026-05-15 | Coloma Jason V | Officer | 34,502 | 2026-05-15 | UBS Financial Services Inc. |
| 2026-03-30 | ATUL DANDEKAR | Officer | 30,000 | 2026-03-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-10 | HAROLD BERNSTEIN | Officer | 74,853 | 2026-03-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-16 | SEKAR KATHIRESAN | Former Director | 29,772 | 2026-01-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-07 | CATHERINE SOHN | Director | 26,920 | 2026-01-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-06 | CATHERINE SOHN | Director | 2,493 | 2026-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | HAROLD BERNSTEIN | Officer | 105,000 | 2025-12-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | ATUL P DANDEKAR | Officer | 87,500 | 2025-12-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-04 | SEKAR KATHIRESAN | Former Board Member | 10,000 | 2025-12-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-21 | SEKAR KATHIRESAN | Former Board Member | 27,500 | 2025-11-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-15 | RICHARD SCHELLER | Director | 20,744 | 2025-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–12 of 12 filings